Skip to main content

Find Clinical Trials

Home
Conditions
Hepatic Encephalopathy

Clinical trial condition

Hepatic Encephalopathy

Explore clinical trials studying Hepatic Encephalopathy. Study availability and eligibility vary by location and protocol.

105 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

Hepatic Encephalopathy trial results

Completed

Safety and Tolerability Study of Rifaximin in Participants With a History of Hepatic Encephalopathy

NCT00686920

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +8 more
Locations: Birmingham, Alabama, United States

Aurora, California, United States

Fresno, California, United States

La Jolla, California, United States

View all 35 locations

View Trial Details

Completed

Effect of Rifaximine on Sleep Disorders in Patients Suffering From Hepatic Encephalopathy

NCT02163837

Conditions: Behavior, Brain Diseases, Brain Diseases, Metabolic, +16 more
Locations: CHU St Pierre Brussels, Belgium

View Trial Details

Completed

Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin (PROSPER)

NCT02488993

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +8 more
Locations: Queen Elizabeth Hospital Birmingham, United Kingdom

View Trial Details

Completed

Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding

NCT02158182

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +11 more
Locations: Hospital General de Mexico Mexico City, Mexico

View Trial Details

Completed

Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal

NCT01059396

Conditions: Ascites, Brain Diseases, Brain Diseases, Metabolic, +18 more
Locations: Hospital German Trias i Pujol Badalona, Spain

Hospital Clinic i Provincial de Barcelona Barcelona, Spain

Hospital de la Santa Creu i Sant Pau Barcelona, Spain

Hospital de la Vall d'Hebron Barcelona, Spain

View Trial Details

Completed

Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-EpidEmiological, Multi-Centre, Study in Patients of PakisTan

NCT02613858

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +8 more
Locations: Baqai Hospital Karachi, Pakistan

Fatima Memorial Hospital Lahore, Pakistan

Lahore General Hospital Lahore, Pakistan

Jinnah Hospital Lahore Lahore, Pakistan

View Trial Details

Completed

L-ornithine L-aspartate in Overt Hepatic Encephalopathy

NCT01722578

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +12 more
Locations: G.B. Pant Hospital New Delhi, India

Department of Gastroenterology, D.M.C. and Hospital Ludhiana, Punjab, India

View Trial Details

Completed

iPod Games in Hepatic Encephalopathy

NCT02154282

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +12 more
Locations: Hunter Holmes McGuire VA Medical Center Richmond, Virginia, United States

View Trial Details

Completed

Effect of Midodrine and Albumine in the Prevention of Complications in Cirrhotic Patients Awaiting Liver Transplantation

NCT00839358

Conditions: Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +29 more
Locations: Hospital Clinic Villarroel 170, Barcelona, Spain

View Trial Details

Completed

N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure

NCT00248625

Conditions: Acute Liver Failure, Brain Diseases, Brain Diseases, Metabolic, +10 more
Locations: University of California, San Francisco San Francisco, California, United States

University of Colorado, Denver Children's Hospital Denver, Colorado, United States

Emory University, Children's Healthcare of Atlanta Atlanta, Georgia, United States

Children's Memorial Hospital Chicago, Illinois, United States

View all 20 locations

View Trial Details